| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding Co Ltd. | Chief Commercial Officer | Common Shares | 1,614 | $239,679 | $148.50 | 03 Oct 2022 | Direct |
| Biohaven Pharmaceutical Holding Co Ltd. | Chief Commercial Officer | Common Shares | 0 | $148.50 | 03 Oct 2022 | By JET Ventures LLC | |
| Biohaven Pharmaceutical Holding Co Ltd. | Chief Commercial Officer | Restricted Share Unit Award | 0 | 03 Oct 2022 | Direct | ||
| Biohaven Pharmaceutical Holding Co Ltd. | Chief Commercial Officer | Stock Options (Right to Buy) | 0 | 03 Oct 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000156218022006956-tilton-john-2022-10-03 | Biohaven Pharmaceutical Holding Co Ltd. | 03 Oct 2022 | 16 | -$992,277 | 4 | Chief Commercial Officer | 03 Oct 2022, 20:27 |
| /report/000156218022000357-tilton-john-2022-01-06 | Biohaven Pharmaceutical Holding Co Ltd. | 06 Jan 2022 | 8 | -$112,320 | 4 | Chief Commercial Officer | 07 Jan 2022, 20:18 |
| /report/000156218021007304-tilton-john-2021-11-25 | Biohaven Pharmaceutical Holding Co Ltd. | 25 Nov 2021 | 3 | -$56,851 | 4 | Chief Commercial Officer | 26 Nov 2021, 15:33 |